Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
OGN
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this pharmaceutical company have re…
Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
New data will represent one of the first large-scale real-world effectiveness analyses of VTAMA cream in patients with atopic dermatitis (AD) JERSEY CITY, N.J., October 01, 2026--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare co…
Organon Canada announces the Approval and Availability of NDUVRA® (tapinarof cream), 1%, a New Steroid-Free Topical Treatment for Moderate to Severe Atopic Dermatitis in Adult and Pediatric Patients 2 Years of Age and Older
KIRKLAND, QC, Sept. 28, 2026 /CNW/ -- Organon Canada, a global healthcare company, today announces the approval and availability of NDUVRA® (tapinarof cream), 1%, for the topical treatment of moderate to severe atopic dermatitis in adult a…
Why MIUDELLA's FDA review matters for Organon stock Organon (OGN) just picked up fresh attention after the FDA accepted a supplemental application to extend use of MIUDELLA, a copper IUD that Organon licensed globally earlier this year. Th…
Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device
Organon (NYSE: OGN) received FDA acceptance to review a supplemental New Drug Application for its hormone free contraceptive device MIUDELLA. The company entered an exclusive global licensing agreement for MIUDELLA, aiming to expand access…
Is Trending Stock Organon & Co. (OGN) a Buy Now?
Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this pharmaceutical company have returned…
PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor
Pharmaceutical R&D and Life Sciences Veterans Will Advise PhaseV as it Scales AI Platform to Bridge the Gap Between Clinical Development Strategy, Execution and Regulatory Submission BOSTON, Sept. 16, 2026 /PRNewswire/ -- PhaseV, a leader…
Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device
Sebela's sNDA Seeks to Extend Approved Duration of Use from 3 to 6 Years JERSEY CITY, N.J., September 14, 2026--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions f…
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of…
Orogen Royalties Acquires Two Gold Projects in Southwest Utah
VANCOUVER, BC / ACCESS Newswire / September 2, 2026 / Orogen Royalties Inc. ("Orogen" or the "Company") (TSXV:OGN)(OTCQX:OGNNF) is pleased to announce the acquisition of the Toro de Oro and El Gigante gold projects in Southwest Utah, USA.…
Arletta Pharma Solutions Jeannette Jager, CEO Arletta Pharma SolutionsJeannette Jager van Dijk, appointed Chief Executive Officer of Arletta Pharma Solutions, effective September 1, 2026. www.arlettapharmasolutions.com Global women's healt…
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
Women's Health Collective Canada The first national investigator-led study focused on Canadian women's experiences of menopause and the menopausal transition is now inviting participants, in partnership with GreenShield and supported by a…
Orogen Royalties Acquires a Royalty on the Haldane Silver Project
VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce it has acquired a 2% Net Smelter Return ("NSR") royalty (the "Royalty") on the Haldane sil…
Orogen Royalties Announces Results of the 2026 Annual General Meeting
VANCOUVER, BC / ACCESS Newswire / August 13, 2026 / Orogen Royalties Inc. ("Orogen" or the "Company") (TSXV:OGN)(OTCQX:OGNNF) is pleased to announce the voting results for its Annual General Meeting (the "Meeting") of shareholders held Aug…
Priori Expands Client Advisory Board with New Members from Fortune 500 Corporate Legal Departments
Priori Legal operations and legal department leaders from Mastercard, Meta, Google, Uber, General Motors, U.S. Bank, Capital One and more will help shape the future of outside counsel management NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) --…
Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability
Healthcare Providers, Healthcare Settings, and Participating Pharmacies Can Now Begin Required Training and Certification in Preparation for MIUDELLA's Launch Later This Year JERSEY CITY, N.J., August 11, 2026--(BUSINESS WIRE)--Organon (NY…
Orogen Royalties Acquires the Two Peaks Project in Arizona
VANCOUVER, BC / ACCESS Newswire / August 5, 2026 / Orogen Royalties Inc. ("Orogen" or the "Company") (TSX.V:OGN) (OTCQX:OGNNF) is pleased to announce the acquisition of the Two Peaks CRD and skarn project in Arizona, USA. Two Peaks Project…
Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2026, Organon (OGN) reported revenue of $1.56 billion, down 2.3% over the same period last year. EPS came in at $0.85, compared to $1.00 in the year-ago quarter. The reported revenue compares to the Zacks Consens…
Organon (OGN) came out with quarterly earnings of $0.85 per share, missing the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $1 per share a year ago. These figures are adjusted for non-recurring items. This quar…
JERSEY CITY, N.J., July 31, 2026--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the company's Board of Director…
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this pharmaceutical company have re…
New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1
The presentation at the 2026 Society for Pediatric Dermatology (SPD) Annual Meeting marked the first time pooled Phase 3 data from the ADORING 1 and 2 trials on Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD®) and…
Organon & Co. Shareholders Clear Sun Pharma Merger Deal
Key Points Interested in Organon & Co.? Here are five stocks we like better. Organon shareholders approved the company's proposed merger with Sun Pharmaceutical Holdings USA, clearing a major step in the deal process. The transaction would…
Organon (OGN) Names A Canada Chief, Is The Stock Cheap?
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Leadership change in Canada puts Organon (OGN) in focus Organon (OGN) is back on investors' radar after Organon Canada appointed Do…
ORGANON CANADA ANNOUNCES THE APPOINTMENT OF DOMINIC BÉGIN AS PRESIDENT AND MANAGING DIRECTOR
25-year industry leader to drive continued growth and expand access to medicines in Canada KIRKLAND, QC, July 22, 2026 /CNW/ -- Organon Canada, a global healthcare company dedicated to improving the health of women, is pleased to announce…
Catalyst watch: Farnborough Air Show, Tesla earnings, AMD AI event, and Samsung reveals
[Skyline of Lower Manhattan] Art Wager Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - JULY 20 * V…
Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
JERSEY CITY, N.J., July 16, 2026--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, plans to release its second quarter 2026 financial r…
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this pharmaceutical company have returned…
Orogen Royalties Inc Begins Trading on OTCQX Best Market
OTC Markets NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Orogen Royalties Inc (TSX-V: OGN; OTCQX: OGNN…
Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1%, at the 2026 Society for Pediatric Dermatology Annual Meeting
New analysis of pooled Phase 3 data will evaluate efficacy and safety of VTAMA cream across age groups in pediatric and adult patients with atopic dermatitis (AD) JERSEY CITY, N.J., July 07, 2026--(BUSINESS WIRE)--Organon (NYSE: OGN), a gl…
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this pharmaceutical c…
Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest
Branded Pharmaceuticals Stocks Q1 Teardown: Zoetis (NYSE:ZTS) Vs The Rest Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let's have a look at Zoetis (NYSE:ZTS) and its peers. Look…
Can Organon & Co. (OGN)’s MIUDELLA Launch Become a Major Driver in Women’s Health Markets?
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Organon & Co. (NYSE:OGN) is one of the best low-priced pharma stocks on this list. TheFly reported on June 22 that OGN announced the completion of a glob…
Orogen Royalties Announces Permitting Update for Portal Construction at Ermitaño's Navidad Deposit
Over 7,700 metres of infill drilling also completed in H1-2026 at Navidad's Winter Vein with multiple significant gold and silver intercepts VANCOUVER, BC / ACCESS Newswire / June 30, 2026 / Orogen Royalties Inc. ("Orogen" or the "Company"…
2 Biotech Stocks Worth Buying Before Their Potential Buyouts
Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the first quarter, the best quarter for the se…